IDDM prevention trials in progress--a critical assessment.
Knip
M
M
Medical School, University of Tampere, Finland.
Akerblom
H K
HK
D016923:Cell Death; D002985:Clinical Protocols; D002986:Clinical Trials as Topic / Q000592:standards*; D003922:Diabetes Mellitus, Type 1 / Q000209:etiology / Q000517:prevention & control*; D005190:Family; D005247:Feeding Behavior; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007328:Insulin / Q000627:therapeutic use*; D008297:Male; D009536:Niacinamide / Q000627:therapeutic use*; D011322:Primary Prevention; D012307:Risk Factors
D007004:Hypoglycemic Agents; D007328:Insulin; D009536:Niacinamide